Infliximab for Crohn's disease in the Swiss IBD cohort study: Clinical management and appropriateness

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 11, 2010, Pages 1352-1357

  Juillerat, Pascal ^a,b   Pittet, Valérie ^b   Vader, John Paul ^b   Burnand, Bernard ^b   Gonvers, Jean Jacques ^a   De Saussure, Philippe ^c   Mottet, Christian ^a   Seibold, Frank ^d   Rogler, Gerhard ^e   Sagmeister, Markus ^f   Felley, Christian ^a   Michetti, Pierre ^a   Froehlich, Florian ^a,g  

^a Department of Gastroenterology and Hepatology ^*  (Australia)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d Spital Bern Tiefenau   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f Division of Gastroenterology   (Switzerland)

^g UNIVERSITY OF BASEL   (Switzerland)

Author keywords

antitumor necrosis factor ; appropriateness; Cohort Study; Crohn's disease; inflammatory bowel disease; infliximab; therapy; treatment

Indexed keywords

INFLIXIMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CROHN DISEASE; DRUG INDICATION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SWITZERLAND;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; GUIDELINE ADHERENCE; HUMANS; MALE; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWITZERLAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78049239029     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32833eaa8a     Document Type: Article

References (24)

1. Rutgeerts P, Vermeire S, Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009; 136:1182-1197.
2. Brook RH, Chassin MR, Fink A, Solomon D.H., Kosecoff J., Park RE A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 1986; 2:53-63.
3. Fitch K, Bernstein SJ, Aguilar M.S., Burnand B., LaCalle JR, Lazaro P, et al The RAND/UCLA appropriateness method user's manual. RAND Corporation 2001; 1-7.
4. Pittet V, Juillerat P, Mottet C., Felley C, Ballabeni P, Burnand B., et al. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol 2009; 38:922-931.
5. Mottet C, Vader J-P, Felley C, Froehlich F., Gonvers J-J, Juillerat P, et al. Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): results of a multidisciplinary international expert panel-EPACT II. J Crohn's Colitis 2009; 3:257-263.
6. Michetti P, Stelle M, Juillerat P., Gassull M, Heil FJ, Stange E, et al Appropriateness of therapy for active Crohn's disease: results of a multidisciplinary international expert panel-EPACT II. J Crohn's Colitis 2009; 3:232-240.
7. Juillerat P, Vader J-P, Felley C, Pittet V., Gonvers J-J, Mottet C, et al. Appropriate maintenance treatment for Crohn's disease: results of a multidisciplinary international expert panel-EPACT II. J Crohn's Colitis 2009; 3:241-249.
8. Felley C, Vader J-P, Juillerat P, Pittet V., O'Morain C, Panis Y, et al. Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: results of a multidisciplinary expert panel-EPACT II. J Crohn's Colitis 2009; 3:250-256.
9. Silverberg MS, Satsangi J, Ahmad T., Arnott ID, Bernstein CN, Brant SR, et al Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A):5-36.
10. Patel MR, Spertus JA, Brindis R.G., Hendel RC, Douglas PS, Peterson ED, et al ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. J Am Coll Cardiol 2005; 46:1606-1613.
11. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris G.J., Kornbluth A., Rachmilewitz D, et al Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362:1383-1395.
12. D'Haens G., Baert F, Van Assche G, Caenepeel P, Vergauwe P., Tuynman H, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008; 371:660-667.
13. Sands B, Anderson FH, Bernstein C.N., Chey WY, Feagan BG, Fedorak RN, et al Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350:876-885.
14. Nielsen OH, Rogler G, Hahnloser D., Thomsen OO Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol 2009; 6:92-106.
15. Gonzalez N, Quintana JM, Lacalle J.R., Chic S., Maroto D. Review of the utilization of the RAND appropriateness method in the biomedical literature (1999-2004). Gac Sanit 2009; 23:232-237.
16. Bernstein SJ, Lazaro P, Fitch K., Aguilar MD, Rigter H, Kahan JP Appropriateness of coronary revascularization for patients with chronic stable angina or following an acute myocardial infarction: multinational versus Dutch criteria. Int J Qual Health Care 2002; 14:103-109.
17. Epstein AM, Ayanian JZ, Keogh J.H., Noonan SJ, Armistead N, Cleary PD, et al Racial disparities in access to renal transplantation: clinically appropriate or due to underuse or overuse? N Engl J Med 2000; 343:1537-1544.
18. Ward RP, Mansour IN, Lemieux N, Gera N., Mehta R, Lang RM Prospective evaluation of the clinical application of the American College of Cardiology Foundation/American Society of Echocardiography Appropriateness Criteria for Transthoracic Echocardiography. J Am Coll Cardiol Img 2008; 1:663-671.
19. Vader JP, Burnand B, Froehlich F., Dubois RW, Bochud M, Gonvers JJ The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): project and methods. Endoscopy 1999; 31:572-578. (Pubitemid 29500507)
20. Seematter-Bagnoud L., Vader JP, Wietlisbach V, Froehlich F., Gonvers JJ, Burnand B. Overuse and underuse of diagnostic upper gastrointestinal endoscopy in various clinical settings. Int J Qual Health Care 1999; 11:301-308.
21. Kaliszan B, Soule JC, Vallot T, Mignon M. Applicability and efficacy of qualifying criteria for an appropriate use of diagnostic upper gastrointestinal endoscopy. Gastroenterol Clin Biol 2006; 30:673-680.
22. Regueiro M, Schraut W, Baidoo L., Kip KE, Sepulveda AR, Pesci M, et al Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 2009; 136:441-450.
23. Siegel C, Melmed G, Ullman T. Improving quality of care in IBD: a STEEEP challenge. Inflamm Bowel Dis 2010; 16:134-136.
24. Kappelman M, Palmer L, Boyle B., Rubin D. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis 2010; 16:125-133.